(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
about
Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.Bone marrow biopsies do not impact response assessment for follicular lymphoma patients treated on clinical trials.Bone marrow biopsy superiority over PET/CT in predicting progression-free survival in a homogeneously-treated cohort of diffuse large B-cell lymphoma.Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma.Overestimated value of FDG-PET based bone marrow evaluation in lymphoma: Response to Adams and Kwee.Overestimated value of FDG-PET based bone marrow evaluation in lymphoma.
P2860
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
@en
type
label
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
@en
prefLabel
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
@en
P2093
P2860
P356
P1476
(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma
@en
P2093
Bruce D Cheson
Chaitra S Ujjani
Elizabeth M Hill
Giuseppe Esposito
Hongkun Wang
Metin Ozdemirli
Samer Nassif
P2860
P304
P356
10.1111/BJH.14071
P407
P577
2016-04-20T00:00:00Z